DAY 1 | Auditorium 1 | Auditorium 2 | Auditorium 3 | Auditorium 4 | ELRIG Tech Theatre - supported by DDW | Learning Zone | DAY 1 |
08:00 |
Registration |
|
|
|
|
Slot
|
08:00 |
08:05 |
|
|
|
|
08:05 |
08:10 |
|
|
|
|
08:10 |
08:15 |
|
|
|
|
08:15 |
08:20 |
|
|
|
|
08:20 |
08:25 |
|
|
|
|
08:25 |
08:30 |
|
|
|
|
08:30 |
08:35 |
|
|
|
|
08:35 |
08:40 |
|
|
|
|
08:40 |
08:45 |
|
|
|
|
|
08:45 |
08:50 |
|
|
|
|
|
08:50 |
08:55 |
|
|
|
|
|
08:55 |
09:00 |
|
|
|
|
|
09:00 |
09:05 |
|
|
|
|
|
09:05 |
09:10 |
Slot Chairs: Catherine Kettleborough, LifeArc, The Accelerator |
|
|
|
|
|
09:10 |
09:15 |
|
|
|
|
|
09:15 |
09:20 |
|
|
|
|
|
09:20 |
09:25 |
|
|
|
|
|
09:25 |
09:30 |
Slot Chairs: Katie Chapman, VC funded Biotech Company Simon Chell, AstraZeneca Jon Hutchinson, GlaxoSmithKline Simon Ward, University of Cardiff |
|
|
|
|
|
09:30 |
09:35 |
Slot New technologies for the design and characterisation of nanotechnology mediated therapeutics 09:35 (45 mins) Molly Stevens, Imperial College London
|
|
|
|
|
|
09:35 |
09:40 |
|
|
|
|
|
09:40 |
09:45 |
|
|
|
|
|
09:45 |
09:50 |
|
|
|
|
|
09:50 |
09:55 |
|
|
|
|
|
09:55 |
10:00 |
|
|
|
|
|
10:00 |
10:05 |
|
|
|
|
|
10:05 |
10:10 |
|
|
|
|
|
10:10 |
10:15 |
|
|
|
|
|
10:15 |
10:20 |
Refreshment Break |
|
|
Slot Chairs: Chris Luche, Sanger Institute Sue Ward, Illumina |
Slot Chairs: Anne Hammerstein, SPT Labtech |
|
10:20 |
10:25 |
|
|
|
10:25 |
10:30 |
|
|
|
10:30 |
10:35 |
|
|
|
10:35 |
10:40 |
|
|
|
|
|
10:40 |
10:45 |
|
|
|
|
|
10:45 |
10:50 |
|
|
|
|
|
10:50 |
10:55 |
|
|
|
|
|
10:55 |
11:00 |
|
|
|
|
|
11:00 |
11:05 |
Slot Chairs: Sian Lewis, MSD Michael Howell, The Francis Crick Institute Session Introduction 11:05 (5 mins) Sian Lewis, MSD Michael Howell, The Francis Crick Institute High Content Imaging as an enabling tool for early drug discovery 11:10 (30 mins) John Bassett, MSD Patient-Derived Cell (PDC) Models as a Tool to Assess Cancer Therapeutic Efficacy Across the Drug Development Life Cycle 11:40 (30 mins) Rachel Howard-Jones — Nexcelom from PerkinElmer Accelerating Drug Discovery with Cell Painting 12:10 (30 mins) James Pilling, AstraZeneca Microplate readers and imaging systems 12:40 (5 mins) Imran Haneef — LabLogic Systems Limited
|
Slot Chairs: Allan Jordan, Sygnature Discovery Sarah Skerrat, CHARM Therapeutics Session Introduction 11:05 (5 mins) Allan Jordan, Sygnature Discovery Sarah Skerrat, CHARM Therapeutics Discovery and validation of in vitro and in vivo probes for human DNA Polymerase theta (Polθ) 11:10 (30 mins) Robert Heald, Artios Pharma The COVID Moonshot – from open science collaboration in fragment screening to drug candidate and beyond to Pandemic Preparedness 11:40 (30 mins) Ed Griffen, MedChemica Ltd ML/AI: Opportunities, Impact and Future Directions in Drug Design 12:10 (30 mins) Sarah Skerrat, CHARM Therapeutics
|
Slot Chairs: Chris Herring, Adaptimmune Claire Dobson, AstraZeneca Session Introduction 11:05 (5 mins) Chris Herring, Adaptimmune Claire Dobson, AstraZeneca TCR Evolution, revolution: How Adaptimmune is developing innovative TCR T-cell therapies to treat solid tumors 11:10 (30 mins) Jo Brewer, Adaptimmune Limited The journey from discovery to therapy begins with a single cell 11:40 (30 mins) Stephen Hague — 10x Genomics From Stem-Cells to T-Cells: Next-Generation DNA NanoVectors -an Alternative Non-Integrating DNA Vector Platform for
Regenerative Medicine and Immunotherapy 12:10 (30 mins) Richard Harbottle, German Cancer Research Centre (DKFZ) Automating high-throughput NGS and qPCR assays: Meet the Biomark™ X and the Juno™ 12:40 (5 mins) James Curtis — Standard Bio Tools
|
Slot Chairs: Anna Morgan, Physiology & Pharmacology, Kingston University Simon Pitchford, King's College London Session Introduction 11:05 (5 mins) Anna Morgan, Physiology & Pharmacology, Kingston University Simon Pitchford, King's College London The burden of unmet needs in COPD 11:10 (30 mins) Wisia Wedzicha, Imperial College London Novel drug targets in COPD 11:40 (30 mins) Ian Adcock, Imperial College London New perspectives for modelling inflammatory diseases using patient-derived organoids 12:10 (5 mins) Sylvia F. Boj — HUB Organoids Use of Imaging for preclinical evaluation of drugs for the treatment of COPD 12:15 (30 mins) Anna Morgan, Physiology & Pharmacology, Kingston University
|
|
|
11:05 |
11:10 |
|
|
11:10 |
11:15 |
|
|
11:15 |
11:20 |
|
|
11:20 |
11:25 |
|
|
11:25 |
11:30 |
|
|
11:30 |
11:35 |
|
|
11:35 |
11:40 |
|
|
11:40 |
11:45 |
|
|
11:45 |
11:50 |
|
|
11:50 |
11:55 |
|
|
11:55 |
12:00 |
|
|
12:00 |
12:05 |
|
|
12:05 |
12:10 |
|
|
12:10 |
12:15 |
|
|
12:15 |
12:20 |
|
|
12:20 |
12:25 |
|
|
12:25 |
12:30 |
|
|
12:30 |
12:35 |
|
|
12:35 |
12:40 |
|
|
12:40 |
12:45 |
Refreshment Break - Poster Session 13.15 - 13.45 |
|
|
|
Slot Chairs: Yahya Anvar, OKRA.ai |
|
12:45 |
12:50 |
|
|
|
12:50 |
12:55 |
|
|
|
12:55 |
13:00 |
|
|
|
13:00 |
13:05 |
|
|
|
|
13:05 |
13:10 |
|
|
|
|
13:10 |
13:15 |
|
|
|
|
13:15 |
13:20 |
|
|
Slot Chairs: Samantha Kanza, University of Southampton |
|
13:20 |
13:25 |
|
|
|
13:25 |
13:30 |
|
|
|
13:30 |
13:35 |
|
|
|
13:35 |
13:40 |
|
|
|
|
13:40 |
13:45 |
|
|
|
|
|
13:45 |
13:50 |
|
|
|
|
|
13:50 |
13:55 |
|
|
|
|
|
13:55 |
14:00 |
Slot Phenonaut; a tool for multiomic data integration, analysis, prediction, and inference 14:00 (30 mins) Steven Shave, University of Edinburgh & GSK 10x Your Lab: High Content Analysis Meets High-Throughput Screening 14:30 (5 mins) Kristin Halfpenny — Araceli Biosciences spheroONE – an automated high throughput spheroid isolation and manipulation technology. 14:35 (5 mins) Alice Cheesbrough — Cellenion Life beyond the pixels: single-cell analysis using deep learning and image analysis methods 14:40 (30 mins) Peter Horvath, Biological Research Centre, Szeged
|
Slot Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery - Design tips and tricks 14:00 (30 mins) Jamie Scott, AstraZeneca Supporting innovations in Splicesome research 14:30 (5 mins) ROSLYN McConnell — Avantor New Approaches to the Synthesis and Application of DNA-Encoded Libraries 14:35 (30 mins) Jessica Graham, Newcastle University Harriet Stanway-Gordon, Newcastle University
|
Slot Pin-point™ – A Modular Base Editing System Driving Cell and Gene therapies 14:00 (30 mins) Michael Anbar, Horizon Discovery, a PerkinElmer company Assist Plus Pipetting Platform 14:30 (5 mins) Sharon Barnard — INTEGRA Biosciences Bioluminescent assay tools for TCR-T and CAR-T development and characterisation 14:35 (5 mins) Craig Malcolm — Promega UK Ltd Armouring CAR-T cells therapy against the immunosuppressive microenvironment in solid tumour 14:40 (30 mins) Romain Lara, AstraZeneca
|
Slot Preclinical translational models for investigating drugs for the treatment of COPD 14:00 (30 mins) Simon Pitchford, King's College London Use of human tissues to investigate drugs for the treatment of COPD 14:30 (30 mins) Luigino Calzetta, University of Parma
|
|
|
14:00 |
14:05 |
|
|
14:05 |
14:10 |
|
|
14:10 |
14:15 |
Slot Chairs: Paul Avery, BioStrata |
|
14:15 |
14:20 |
|
14:20 |
14:25 |
|
14:25 |
14:30 |
|
14:30 |
14:35 |
|
14:35 |
14:40 |
|
14:40 |
14:45 |
|
14:45 |
14:50 |
|
14:50 |
14:55 |
|
14:55 |
15:00 |
|
|
15:00 |
15:05 |
|
|
15:05 |
15:10 |
Refreshment Break |
|
|
|
|
|
15:10 |
15:15 |
|
|
Slot Chairs: Tom Froggatt, Singular Talent |
Slot Chairs: Zoe Hughes-Thomas, GSK |
|
15:15 |
15:20 |
|
|
|
15:20 |
15:25 |
|
|
|
15:25 |
15:30 |
|
|
|
15:30 |
15:35 |
|
|
|
|
|
15:35 |
15:40 |
|
|
|
|
|
15:40 |
15:45 |
Slot Morphological trajectory inference: Tracking cell state transitions and the impact of small-molecule perturbations 15:45 (30 mins) Rebecca Hughes, University of Edinburgh Magnetic Electrospun Microfibre Scaffold Assemblies: Examples of there use for Cell-Based Screening Applications 16:15 (15 mins) Gary Allenby — Charnwood Molecular Quantitative high-throughput screening of single cancer cell phenotypes in 3D matrices 16:30 (30 mins) Vicky Bousgouni, Institute of Cancer Research
|
Slot Targeting the template: A novel therapeutic strategy for prion diseases 15:45 (30 mins) Heulyn Jones, Cardiff University Navigate Your Chemistry And Explore The Biology - Case Studies Of CETSA® overcoming challenges in Drug Discovery 16:15 (15 mins) Isabel Martin Caballero — Pelago Bioscience AB Audience Lead Panel Discussion with Q&A 16:30 (30 mins) Allan Jordan, Sygnature Discovery Sarah Skerrat, CHARM Therapeutics
|
Slot Unlocking a revolutionary class of in vivo reprogramming therapies through systematic, unbiased identification of the key cell switches controlling cell fate 15:45 (30 mins) Louise Modis, Mogrify The impact of not understanding the genetic landscape, Ignorance will cost you time and money. 16:15 (15 mins) Melanie Maerken — Synthego Next Generation Platforms for Human Gene Therapy 16:30 (30 mins) Aravind Asokan, Duke University
|
Slot Early experimental medicine studies for investigating new drugs for COPD 15:45 (30 mins) Dave Singh, University of Manchester Methods to tackle novel molecular targets involved in inflammatory disease 16:15 (15 mins) Mark Abbott — Peak Proteins Ltd Publishing in the British Journal of Pharmacology 16:30 (30 mins) Charles Whalley, British Pharmacological Society
|
|
|
15:45 |
15:50 |
|
|
15:50 |
15:55 |
|
|
15:55 |
16:00 |
|
|
16:00 |
16:05 |
|
|
16:05 |
16:10 |
|
|
16:10 |
16:15 |
|
|
16:15 |
16:20 |
|
|
16:20 |
16:25 |
|
|
16:25 |
16:30 |
|
|
16:30 |
16:35 |
|
|
16:35 |
16:40 |
|
|
16:40 |
16:45 |
|
|
16:45 |
16:50 |
|
|
16:50 |
16:55 |
|
|
16:55 |
17:00 |
|
|
|
|
|
|
17:00 |
17:05 |
|
|
|
|
|
17:05 |
17:10 |
|
|
|
|
|
17:10 |
17:15 |
|
|
|
|
Slot
|
17:15 |
17:20 |
|
|
|
|
17:20 |
17:25 |
|
|
|
|
17:25 |
17:30 |
|
|
|
|
17:30 |
17:35 |
|
|
|
|
17:35 |
17:40 |
|
|
|
|
17:40 |
17:45 |
|
|
|
|
17:45 |
17:50 |
|
|
|
|
17:50 |
17:55 |
|
|
|
|
17:55 |
18:00 |
|
|
|
|
18:00 |
18:05 |
|
|
|
|
18:05 |
18:10 |
|
|
|
|
18:10 |
18:15 |
|
|
|
|
|
18:15 |
18:20 |
|
|
|
|
|
18:20 |
18:25 |
|
|
|
|
|
18:25 |
18:30 |
|
|
|
|
|
18:30 |
18:35 |
|
|
|
|
|
18:35 |
18:40 |
|
|
|
|
|
18:40 |
18:45 |
|
|
|
|
|
18:45 |
18:50 |
|
|
|
|
|
18:50 |
18:55 |
|
|
|
|
|
18:55 |
19:00 |
|
|
|
|
|
|
19:00 |